Literature DB >> 17845138

Hide-and-seek: the challenge of viral persistence in HIV-1 infection.

Luc Geeraert1, Günter Kraus, Roger J Pomerantz.   

Abstract

The success of highly active antiretroviral therapy (HAART) for HIV-1 infection has sparked interest in mechanisms by which the virus can persist despite effectively suppressive therapy. Latent HIV-1 reservoirs established early during infection not only prevent sterilizing immunity but also represent a major obstacle to virus eradication. When HIV-1 gains a foothold in the immunologic memory or in certain inaccessible compartments of the human body, it cannot be easily purged by HAART and is able to replenish systemic infection on treatment interruption. Because latently infected cells are indistinguishable from uninfected cells, deliberate activation of latent infection combined with intensified HAART seems to be the best strategy to combat latent infection. Initial hypothesis-driven clinical trials did not achieve their ultimate goal, although they provided valuable insight for the design of future eradication protocols. A more detailed understanding of the basic mechanisms underlying the establishment and long-term maintenance of HIV-1 reservoirs will be critical in developing new eradication approaches.

Entities:  

Mesh:

Year:  2008        PMID: 17845138     DOI: 10.1146/annurev.med.59.062806.123001

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  57 in total

1.  The viral protein Tat can inhibit the establishment of HIV-1 latency.

Authors:  Daniel A Donahue; Björn D Kuhl; Richard D Sloan; Mark A Wainberg
Journal:  J Virol       Date:  2012-01-11       Impact factor: 5.103

2.  Combinatorial latency reactivation for HIV-1 subtypes and variants.

Authors:  John C Burnett; Kwang-Il Lim; Arash Calafi; John J Rossi; David V Schaffer; Adam P Arkin
Journal:  J Virol       Date:  2010-03-31       Impact factor: 5.103

3.  Isolation of a cellular factor that can reactivate latent HIV-1 without T cell activation.

Authors:  Hung-Chih Yang; Lin Shen; Robert F Siliciano; Joel L Pomerantz
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-31       Impact factor: 11.205

4.  The majority of HIV type 1 DNA in circulating CD4+ T lymphocytes is present in non-gut-homing resting memory CD4+ T cells.

Authors:  Kristin McBride; Yin Xu; Michelle Bailey; Nabila Seddiki; Kazuo Suzuki; John M Murray; Yuan Gao; Celine Yan; David A Cooper; Anthony D Kelleher; Kersten K Koelsch; John Zaunders
Journal:  AIDS Res Hum Retroviruses       Date:  2013-10       Impact factor: 2.205

5.  Latent HIV-1 can be reactivated by cellular superinfection in a Tat-dependent manner, which can lead to the emergence of multidrug-resistant recombinant viruses.

Authors:  Daniel A Donahue; Sophie M Bastarache; Richard D Sloan; Mark A Wainberg
Journal:  J Virol       Date:  2013-06-26       Impact factor: 5.103

6.  Treatment of chronically FIV-infected cats with suberoylanilide hydroxamic acid.

Authors:  Samantha J McDonnel; Molly L Liepnieks; Brian G Murphy
Journal:  Antiviral Res       Date:  2014-06-02       Impact factor: 5.970

7.  Synthesis, docking, and biological studies of phenanthrene β-diketo acids as novel HIV-1 integrase inhibitors.

Authors:  Horrick Sharma; Tino W Sanchez; Nouri Neamati; Mervi Detorio; Raymond F Schinazi; Xiaolin Cheng; John K Buolamwini
Journal:  Bioorg Med Chem Lett       Date:  2013-09-11       Impact factor: 2.823

8.  BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism.

Authors:  Daniela Boehm; Vincenzo Calvanese; Roy D Dar; Sifei Xing; Sebastian Schroeder; Laura Martins; Katherine Aull; Pao-Chen Li; Vicente Planelles; James E Bradner; Ming-Ming Zhou; Robert F Siliciano; Leor Weinberger; Eric Verdin; Melanie Ott
Journal:  Cell Cycle       Date:  2012-02-01       Impact factor: 4.534

9.  Combined effect of antiretroviral therapy and blockade of IDO in SIV-infected rhesus macaques.

Authors:  Adriano Boasso; Monica Vaccari; Dietmar Fuchs; Andrew W Hardy; Wen-Po Tsai; Elzbieta Tryniszewska; Gene M Shearer; Genoveffa Franchini
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

Review 10.  Cellular reservoirs of HIV-1 and their role in viral persistence.

Authors:  Aikaterini Alexaki; Yujie Liu; Brian Wigdahl
Journal:  Curr HIV Res       Date:  2008-09       Impact factor: 1.581

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.